NuVasive, Inc. (NASDAQ: NUVA) has appointed Michael J. Lambert as their Executive Vice President and Chief Financial Officer. Mr. Lambert will assume the position on November 9, 2009. The company has also announced several other Executive Management Team updates. Mr. Lambert will succeed Kevin O'Boyle, who has served as the CFO since the company went public in 2004. Mr. O'Boyle will assist Mr. Lambert's transition into his new role through the end of the year.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About NuVasive
NuVasive is a medical device company focused on the design, development, and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused primarily on the $4.6 billion U.S. spine implant market. Additionally, the Company has expanded into the $1.5 billion global biologics market, the $1.5 billion international market, and is developing products for the emerging motion preservation market.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
